Okey!
Trying to leave the microcosmos just for a little while and put a
clinical view on this topic.
I have´nt read all threads , so if I am repeating any earlier
discussion or point of view, please bear vith me.
As a clinician , prescribing any treatment, it always come to waying
the risks against the benefits in a long term as well as short term
timeperspective. There are a substantial body of evidence on treating
children diagnosed as ADDH with amphetamine and metamphetamine , where
we find on long term follow-up , that the child has a great benefit
with treatment regarding academic achievements, family function,
sociability,etcetera,etcetera. as opposed to the untreated wich has a
signifiquant risk of future criminal behavior and drugaddiction. In a
Swedish material it has been found that 50% of the heroineaddicts
(intravenous) was diagnosed with ADDH in adulthood. 40% of the inmates
in prisons had a neuropsychiatric condition. and so on.
The problem lies in the fact that all mechanisms on cell level and
transmittorinteractions are not fully understood (wich this board is
an excellent example of) and the long-term consequences on the
immature and developing brain still are to a great extent unknown.
Anyway it is my strong opinion that the benefits from treatment
strongly outmatches the today known risks , and that it is morally and
ethically impossible to refuse treatment with these drugs.
orkeltatte